In summary, our study reveals that NAT10 is regulated by the upstream signal YAP1 and promotes the malignant progression of HB by mediating ac4C modification to upregulate the expression of G6PD and activate the PPP (Fig 8). The gene discussed is NAT10; the disease is hemoglobin measurement.